MeSH D001249 - asthma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001982:Bronchial diseases
0 Companies
0 Drugs
Success rate
D012130:Respiratory hypersensitivity
D008173:Obstructive lung diseases
D001249:Â
Asthma
D000080445:Asthma-chronic obstructive pulmonary disease overlap syndrome
0 Companies
0 Drugs
Success rate
D001250:Exercise-induced asthma
0 Companies
0 Drugs
Success rate
D013224:Status asthmaticus
D055963:Aspirin-induced asthma
0 Companies
0 Drugs
Success rate
D059366:Occupational asthma
0 Companies
0 Drugs
Success rate
D000096823:Cough-variant asthma
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| 3M | Theophylline | Theolair |  | 1982-01-01 |  |  |
| Theophylline | Theolair-sr |  | 1987-07-16 |  |  | |
| A.H. Robins Company | Methylprednisolone | Methylprednisolone |  | 1982-01-01 |  |  |
| Prednisolone | Prednisolone |  | 1982-01-01 |  |  | |
| Cortisone | Cortisone |  | 1982-01-01 |  |  | |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Dextromethorphan, Pseudoephedrine, Brompheniramine | Dimetane-dx |  | 1984-08-24 |  |  | |
| Aminophylline | Aminophylline |  | 1982-01-01 |  |  | |
| Abbott Biotherapeutics | Methylprednisolone | A-methapred |  | 1991-02-22 |  |  |
| AbbVie | Prednisolone | Pred |  | 1982-01-01 |  |  |
| Prednisolone | Pred Mild |  | 1982-01-01 |  |  | |
| Able Laboratories | Theophylline | Theophylline |  | 2004-04-27 |  |  |
| Accord Healthcare | Montelukast | Montelukast |  | 2012-09-21 |  |  |
| Acella Pharmaceuticals | Dextromethorphan, Pseudoephedrine, Brompheniramine | Brompheniramine Maleate, Pseudoephedrine Dextromethorphan |  | 2016-09-20 |  |  |
| Aizant Drug Research Solutions | Albuterol | Albuterol |  | 2019-03-15 |  |  |
| Zileuton | Zileuton |  | 2020-10-23 |  |  | |
| Ajanta Pharma | Montelukast | Montelukast |  | 2015-07-31 |  |  |
| Akorn | Cromolyn | Cromolyn |  | 1998-04-29 |  |  |
1
2
3
4
5
6
...
18
>
Clinical Trials
Historical Success Rate
Phase 1
68%64/94
Phase 2
53%66/125
Phase 3
71%106/149
Approved: 48Overall Success rate: 26%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
12
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use